Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessOmnicell Target Price Lowered Amid Uncertain Growth Outlook

Omnicell Target Price Lowered Amid Uncertain Growth Outlook

Add to Favorite
Added to Favorite


BofA Securities analysts adjusted their price target for Omnicell (NASDAQ:OMCL) from $57 to $54, maintaining a Neutral rating on the stock. This revision follows insights from the Facilities and Managed Care Team’s latest quarterly capital expenditure survey, which provides early indicators for 2025 pharmacy IT budget growth.
According to the survey, 2025 pharmacy IT budgets are projected to grow by 4% year-over-year, slightly down from the 4.6% growth forecasted for 2024. Broader capital expenditure trends remain positive, with improving access to financing, fewer project delays or cancellations, and reduced disruptions tied to Change Healthcare. While these factors, along with new product extensions like XT Amplify, support potential growth for Omnicell, the long-term revenue trajectory remains uncertain due to limited visibility on the product revenue ramp.
Omnicell maintains a strong position within the pharmacy automation market, yet the uncertainty surrounding its future growth limits confidence.

Subscribe to get Latest News Updates

Latest News

You may like more
more

CyberArk Software Ltd. (NASDAQ:CYBR): A Leader in Cybersecurity Solutions

CyberArk's consensus price target has been on the rise,...

Lattice Semiconductor Corporation’s Financial Efficiency Outshines Peers

Lattice Semiconductor Corporation (NASDAQ:LSCC) demonstrates superior financial efficiency with...

Broadridge Financial Solutions, Inc. (NYSE:BR) Insider Stock Sale and Participation in Wealth Symposium

Broadridge Financial Solutions, Inc. (NYSE:BR) is a leading fintech...

Claros Mortgage Trust Inc (NYSE:CMTG) Faces Market Challenges Despite Strong Earnings

Claros Mortgage Trust Inc (NYSE:CMTG) surpasses earnings expectations with...